1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019

REPORT DESCRIPTION

Global Market Watch:
Global Regenerative Medicine market is estimated to reach US$24.7 billion by 2017. Regenerative Medicine in Orthopedics market is projected to reach US$10.3 billion by 2017, growing at a CAGR of 12.2% for the analysis period 2013-2019 respectively. Skin/Integumentary and Urology together account for approximately 25.97% (2016) of the market are expected to support the Regenerative Medicine Industry going forward. Geographical analysis for Regenerative Medicine in Cardiology shows that the highest Compounded Annual Growth Rate (CAGR) of 18.1% is anticipated from Asia-Pacific region during the analysis period 2013-2019.

Report Focus:
The report ‘Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019’ reviews the latest trends in regenerative medicine with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations. The report primarily focuses on:

- Emerging Market Trends
- Advancements in the Technological Space
- Market Demand of The Segments (By-Region)
- Key Growth Areas and Market Size
- Region-Wise Demand Factor
- Key Competitors Edge
- Investment Strategies

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

The analysis primarily deals by therapeutic area and biological substitutes. Further, the subdivided categories include:
Regenerative Medicine – Segmentation
- Therapeutic Area
o Orthopedics
o Skin/Integumentary
o Cardiology
o Neurology
o Urology
o Other
- Biological Substitutes
o Cells and Biomaterials
o Biomolecules
o Manufacturing Factors and
o Other

The period considered for the regenerative medicine market analysis is 2013-2019. The region wise distribution of the market consists of The Americas (USA, Brazil, Canada and Rest of The Americas), Europe (Germany, United Kingdom, France, Switzerland, Spain, The Netherlands, Russia and Rest of Europe), Asia-Pacific (Japan, South Korea, Australia, China, India and Rest of Asia-Pacific) and Rest of World (Africa and Middle East). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually.

More than 600 market players are identified in regenerative medicine industry out of which 21 key companies that project improved market activities in the near future are profiled. The report consists of 99 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Table Of Contents

Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019
TABLE OF CONTENTS
I. REPORT FOCUS

I. INTRODUCTION

A. REGENERATIVE MEDICINE - IN BRIEF
HISTORY OF ORGAN ENGINEERING

THE METHODOLOGY OF REGENERATIVE MEDICINE
1) HUMAN SUBSTANCES
2) CELLS AND TISSUES
3) EMBRYONIC STEM CELLS
NUCLEAR TRANSPLANTATION
OPPOSITION TO USE OF EMBRYONIC STEM CELLS AND NUCLEAR TRANSPLANTATION

4) NOVEL MATERIALS
THE COMPETENT ASSOCIATION BETWEEN REGENERATIVE MEDICATION AND PHYSICAL THERAPEUTICS
CLINICAL TOOLS AND SYNTHETIC ORGANS
MATERIAL TREATMENTS AND BIO SUBSTANCES
CELLULAR TREATMENTS
PREVALENT HURDLES IN THE PROGRESS OF CELLULAR THERAPIES
BARRIERS
SKELETAL MUSCLE
CARDIAC
BONE
OBJECTIVE MEASURES TOWARD REGENERATIVE REHABILITATION
CONCLUSIONS

B. TISSUE ENGINEERING
REGENERATIVE MEDICINE AND TISSUE ENGINEERING
HISTORY OF TISSUE ENGINEERING
METHODS OF TISSUE ENGINEERING
TISSUE ENGINEERING AND REGENERATIVE MEDICINE IN THE CURRENT MEDICAL ORDER
NIH SPONSORED RESEARCH IN TISSUE ENGINEERING AND REGENERATIVE MEDICINE
INFLUENCING STEM CELLS BY MANIPULATING THEIR ENVIRONMENT
TRANSPLANTING HUMAN LIVERS IN MICE
ENGINEERING MATURE BONE STEM CELLS
USING LATTICES TO HELP ENGINEERED TISSUE SURVIVE
POSSIBLE TREATMENT OPTION FOR WORN OUT/INJURED KNEES
RE-GROWING A NEW KIDNEY

TISSUE ENGINEERING AND BIOMATERIALS
CELL AND TISSUE BANKING STANDARDS AND ACCREDITATION

C. STEM CELLS
INTRODUCTION TO STEM CELLS
HISTORY OF STEM CELLS

TYPES OF STEM CELLS
1) EMBRYONIC STEM (ES) CELLS AND EPIBLAST STEM CELLS
2) NON-EMBRYONIC STEM CELLS (NON-ESC)
TISSUE STEM CELLS
INDUCED PLURIPOTENT STEM (IPS) CELLS

REGENERATIVE MEDICINE AND STEM CELLS
THE MICROENVIRONMENT OF THE STEM CELL
EMBRYONIC STEM CELLS A MORE DETAILED LOOK
BLASTOCYST AS A SOURCE OF STEM CELLS LEGAL ISSUES
NON-EMBRYONIC STEM CELLS
1) AMNIOTIC FLUID DERIVED STEM CELLS
2) CORD BLOOD STEM CELLS
TYPE-1 DIABETES
CARDIOVASCULAR CONDITIONS
CENTRAL NERVOUS SYSTEM

3) BONE-MARROW DERIVED STROMAL STEM CELLS
4) IN-VITRO MSC DIFFERENTIATION
5) STEM CELLS DERIVED FROM FAT TISSUE
6) MONOCYTES

STEM CELL TREATMENTS WHY HAVEN'T THEY GAINED WIDESPREAD POPULARITY?

APPLICATIONS OF STEM CELLS IN TREATMENT OF VARIOUS DISEASES AND CONDITIONS

A) BONE
I) BONE DEFECTS
II) FRACTURE NON-UNION
III) OSTEOGENESIS IMPERFECTA

B) CARTILAGE

C) CARDIAC MUSCLE

D) URINARY TISSUES - BLADDER

E) SPINAL CORD

CONCLUSION

CELL-BASED THERAPIES
CELLS DEVELOPED TODAY ARE FUTURE THERAPIES

D. BIOLOGICAL SUBSTITUTES FOR REGENERATIVE MEDICINE
AREAS IN HUMAN TISSUE CONSTRUCTION
BIOMATERIALS
CELLS
BIOMOLECULES
SAFETY AND PRESENTATION CONCERNS
DEVELOPMENTAL FEATURES
OTHER FACTORS

E. REGENERATIVE MEDICINE AND VARIOUS CONDITIONS
1. SKIN/ INTEGUMENTARY
SKIN-TREATMENT
SKIN REVIVAL
NERVE REVIVAL
SKELETAL MUSCLE REVIVAL

REGENERATIVE DRUGS FOR SKIN DISEASES IPS CELLS TO THE SALVAGE

SKIN AND CUTANEOUS CELLS AND TISSUE APPLICATIONS OPT FOR DEVELOPMENT

DO-US ASSOCIATION IN REGENERATIVE MEDICINE TO SUPPORT ACID ATTACK VICTIMS

2. REGENERATIVE MEDICINE'S PROGRESS IN ORTHOPEDICS
CONTEMPORARY NOTIONS
APPROACHES
CELLS
MORPHOGENETIC STIMULUS
SCAFFOLDS
MECHANICAL STIMULATION
ADVANCEMENT
BONE

REGENERATIVE MEDICINE IN THE BONE
CARTILAGE
OTHER ORGANS
A. INTERVERTEBRAL DISK
B. MENISCUS
C. LIGAMENT AND TENDON

GENE THERAPY STRATEGY

GENE THERAPY COMMERCIAL MILESTONES
2013
2012
2010

VIEWPOINTS

3. CARDIAC REGENERATIVE MEDICINE
CARDIOVASCULAR AND REGENERATIVE MEDICINE
OUTLINE
TYPE OF CVD

CARDIOVASCULAR DISEASE AND REVIVAL MEDICINE
AASTROM
AMORCYTE
ATHERSYS INC.'S
CAPRICOR
CYTOMEDIX
CYTORI THERAPEUTICS
JUVENTAS THERAPEUTICS
MESOBLAST'S

4. REGENERATIVE DRUGS FOR NEUROLOGICAL DISABILITIES
REGENERATIVE DRUGS FOR NEUROLOGICAL DISEASES WITH THE USE OF ELECTRICAL STIMULATION
1. INTRODUCTION
2. ELECTRICAL STIMULUS FOR CEREBRAL INFARCTION
3. LONG-TERM POTENTIATION AND NEUROGENESIS
CONCLUSION

5. REGENERATIVE NEPHROLOGY
REGENERATIVE DRUG STRATEGIES TO HEAL NEUROGENIC BLADDER
INTRODUCTION

6. THE ESSENTIALS OF TISSUE ENGINEERING
BIO-SUBSTANCES USED IN GENITOURINARY TISSUE RENOVATION
CELLS FOR UROGENITAL TISSUE REGENERATION TECHNOLOGIES
TISSUE PROGRAMMING STRATEGIES FOR BLADDER BOOST AND REPLACEMENT
BIOSUBSTANCES SCAFFOLDS FOR BLADDER REGENERATION
REGENERATIVE DRUGS FOR BLADDER USING CELL TRANSPLANTATION
CONCLUSION

7. DIABETES AND REGENERATIVE MEDICINE

8. ALZHEIMER'S AND REGENERATIVE MEDICINE

9. AUTOIMMUNE DISORDERS AND REGENERATIVE MEDICINE

10. REGENERATIVE MEDICINE IN OPHTHALMOLOGY - PROSPECT
PREAMBLE
CELLULAR TREATMENTS
RESULTS - ADVANTAGES
LIMITATIONS

BIO-SUBSTANCES IN THE CORNEA
CORNEAL REPLACEMENTS ARE A POSSIBLE OPTION THAT NEEDS TO ADDRESS
BIO-SUBSTANCES NEED TO BE
OVERVIEW OF KPRO

EXERCISE ENGINEERING STRUCTURE TO CORNEAL DISEASE

F. REGENERATIVE MEDICINE THE FUTURE TRENDS
ALTERED DEMOGRAPHICS CREATE GREATER BURDEN OF CHRONIC DISEASE
AN EMERGING INDUSTRY
OBTAINING REGULATORY NORMS IN PLACE
FDA PROCEDURES
CROSS-AGENCY MANAGEMENT
REGULATORY DISCIPLINE

G. GOVERNMENT FUNDING
PUBLIC AND PRIVATE INVESTMENT EXCEEDS $1 BILLION

H. US HEALTHCARE STATISTICS
THE COST IMPACT OF AN AGING POPULATION
POTENTIAL ECONOMIC IMPACT OF REGENERATIVE MEDICINE

II. REGENERATIVE MEDICINE - MARKET BRIEFING
THE AMERICAS
EUROPE
ASIA-PACIFIC
REST OF WORLD

II. MARKET ANALYSIS
REGENERATIVE MEDICINE - INDUSTRY SNAPSHOT

A. REGENERATIVE MEDICINE - SEGMENTATION

REGENERATIVE MEDICINE - GLOBAL
REGENERATIVE MEDICINE - BY GEOGRAPHY
THE AMERICAS
EUROPE
ASIA-PACIFIC
REST OF WORLD

REGENERATIVE MEDICINE - BY THERAPEUTIC AREA
REGENERATIVE MEDICINE - THERAPEUTIC AREA - BY GEOGRAPHY
ORTHOPEDICS
THE AMERICAS
EUROPE
ASIA-PACIFIC
REST OF WORLD

SKIN/INTEGUMENTARY
THE AMERICAS
EUROPE
ASIA-PACIFIC
REST OF WORLD

CARDIOLOGY
THE AMERICAS
EUROPE
ASIA-PACIFIC
REST OF WORLD

NEUROLOGY
THE AMERICAS
EUROPE
ASIA-PACIFIC
REST OF WORLD

UROLOGY
THE AMERICAS
EUROPE
ASIA-PACIFIC
REST OF WORLD

OTHER THERAPEUTIC AREAS (REGENERATIVE MEDICINE)
THE AMERICAS
EUROPE
ASIA-PACIFIC
REST OF WORLD

REGENERATIVE MEDICINE - BIOLOGICAL SUBSTITUTES - BY TYPE

B. GROWTH RATE ANALYSIS
A. REGENERATIVE MEDICINE MARKET GROWTH RATES - BY GEOGRAPHY
B. REGENERATIVE MEDICINE MARKET - BY THERAPEUTIC AREA GROWTH RATES

C. INVESTMENT FOCUS

III. INDUSTRY OVERVIEW
A. INDUSTRY ACTIVITIES
E. KEY COMPANY PROFILES
THE AMERICAS
EUROPE
ASIA-PACIFIC
REST OF WORLD

IV. INDUSTRY COMPANY DATABASE

V. APPENDIX
RESEARCH FOCUS
DATA ANALYSIS
CURRENCY EXCHANGE RATES
ABOUT AXIS RESEARCH MIND
DISCLAIMER
FEEDBACK

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Regenerative Medicine Market: By Therapy (Cell Therapy, Gene Therapy, Others), By Product (Autologous Cell-Based, Allogeneic Cell-Based, Acellular), By Application (Orthopaedic & Musculoskeletal Spine, Dermatology, Others) & By Region-Forecast (2016-2021)

Regenerative Medicine Market: By Therapy (Cell Therapy, Gene Therapy, Others), By Product (Autologous Cell-Based, Allogeneic Cell-Based, Acellular), By Application (Orthopaedic & Musculoskeletal Spine, Dermatology, Others) & By Region-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Regenerative medicines are capable of restoring the functionality of cells & tissues by treating a patient with laboratory grown cells and tissues. Regenerative medicines are used in a wide range of degenerative ...

Regenerative Medicine Market: Global Industry Analysis and Opportunity Assessment, 2015-2019

Regenerative Medicine Market: Global Industry Analysis and Opportunity Assessment, 2015-2019

  • $ 5000
  • Industry report
  • August 2016
  • by Future Market Insight Global & Consulting Pvt Ltd

REPORT DESCRIPTION This report analyzes the current and future prospects of the regenerative medicine across the globe. Regenerative medicine is considered as an emerging field of medical science that ...

Tissue Engineering - Global Market Outlook (2016-2022)

Tissue Engineering - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Tissue Engineering market is expected to grow from $6.24 billion in 2015 to reach $14.86 billion by 2022 with a CAGR of 13.2%. Growing usage of tissue engineering ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.